Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pain and Cognition in Multiple Sclerosis.
Multiple sclerosis: evaluation of purine nucleotide metabolism in central nervous system in association with serum levels of selected fat-soluble antioxidants.
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
Laquinimod in the treatment of multiple sclerosis: a review of the data so far.
Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis.
Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity.
[Evaluation of the autonomic regulation of the cardiac oxygen supply of measured physical activity in patients with remitting multiple sclerosis.]
[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)].
Comparison of Vitamin D3 Serum Levels in New Diagnosed Patients with Multiple Sclerosis versus Their Healthy Relatives.
Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Inhibition of System Xc- Transporter Attenuates Autoimmune Inflammatory Demyelination.
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
Kinetics of IL-6 production defines T effector cell responsiveness to regulatory T cells in multiple sclerosis.
[Molecular targeted therapy for neuroimmunological diseases].
Pediatric Multiple Sclerosis: Current Concepts and Consensus Definitions.
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study.
Meningeal inflammation in multiple sclerosis: The key to the origin of cortical lesions?
A role for HLA-DRB1*1101 and DRB1*0801 in cognitive ability and its decline with age.
Multiple sclerosis in India: An overview.
A spring to summer shift of pro-inflammatory cytokine production in multiple sclerosis patients.
The use of transcranial magnetic stimulation in diagnosis, prognostication and treatment evaluation in multiple sclerosis.
Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells.
Pages
« first
‹ previous
…
576
577
578
579
580
581
582
583
584
…
next ›
last »